Kyprolis 60 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJH8U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,525
Award facts
- Contract value 100% obligated
- $17,525.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $17,525.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Kyprolis 60 mg vials, with an ultimate completion date of February 5, 2026. This contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supplier to furnish an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The DLA Troop Support's strategic approach involves multiple awards across different regions through the Pharmaceutical Prime Vendor Global Program Generation V contracts, allowing AmerisourceBergen to serve customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJH8U?
SPE2DR26FJH8U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH8U worth?
The government has obligated $17,525 on SPE2DR26FJH8U.
Is contract SPE2DR26FJH8U an order under another contract?
Yes. SPE2DR26FJH8U is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH8U competed?
The extent of competition for SPE2DR26FJH8U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award